TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Galecto Biotech AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
1,092
|
0 |
| Financial expenses |
251
|
992
|
17 |
| Earnings before taxes |
-30,569
|
-50,234
|
-3,501 |
| EBITDA |
-30,509
|
-49,340
|
-3,521 |
| Total assets |
8,192
|
17,784
|
1,398 |
| Current assets |
4,290
|
12,809
|
1,113 |
| Current liabilities |
6,419
|
15,314
|
235 |
| Equity capital |
1,773
|
2,470
|
1,163 |
| - share capital |
243
|
243
|
24 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
21.6%
|
13.9%
|
83.2% |
| Turnover per employee |
0
|
546
|
0 |
| Profit as a percentage of turnover | -4600.2% | ||
| Return on assets (ROA) |
-370.1%
|
-276.9%
|
-249.2% |
| Current ratio |
66.8%
|
83.6%
|
473.6% |
| Return on equity (ROE) |
-1724.1%
|
-2033.8%
|
-301.0% |
| Change turnover |
-1,096
|
1,092
|
0 |
| Change turnover % | -100% | ||
| Chg. No. of employees |
0
|
0
|
1 |
| Chg. No. of employees % |
0%
|
0%
|
100% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.